THE MORNING SCAN
Friday, February 27, 2026
Tim Bohen
Tim Bohen ยท Scanner & Technical Analysis

EDSA Scanner Alert: 40% Biotech Runner Hits Perfect Fib Setup

My morning scan caught this FDA catalyst play with textbook Fibonacci levels and massive volume confirmation.

๐Ÿ“ก Today's Pick +40.1%
EDSA $2.20
Edesa Biotech, Inc. Common Shares ยท PHARMACEUTICAL PREPARATIONS
Volume
43.2M
Float
8.3M
Catalyst
FDA
Market Cap
$13M
Day Low
$1.51
Day High
$2.58
๐Ÿ“ Fibonacci Trade Plan R:R 1:2.4
โœ‚๏ธ Cut Loss
$1.92
38.2% Fib
๐ŸŽฏ Target 1
$2.58
Day High
๐ŸŽฏ Target 2
$2.87
127.2% Ext
๐Ÿš€ Target 3
$3.24
161.8% Ext
CUT
NOW
T1
T2
Risk / Share
$0.28
Risk : Reward
1:2.4
Upside to T2
$0.67
๐ŸŸข Bull Case
โ–ฒ Trading at 61.8% Fib level ($2.17) which is holding as key support
โ–ฒ Massive 43.2M volume on 8.3M float shows institutional interest
โ–ฒ FDA catalyst in pharmaceutical sector provides fundamental driver
๐Ÿ”ด Bear Case
โ–ผ Break below 38.2% Fib level at $1.92 would invalidate the setup
โ–ผ Small $12.9M market cap makes this highly volatile and risky
โ–ผ Already up 40% - late entries face significant downside risk
๐Ÿ“Š Also on the Scanner
Ticker Company Change Volume
BATL Battalion Oil Corporation +8.02% 56.1M
โœ๏ธ Tim Bohen's Analysis

The pre-market scanner lit up this morning, and EDSA was flashing all the right signals. Here's what caught my attention: a biotech with an FDA catalyst, explosive volume, and what turned out to be a textbook Fibonacci setup that's still playing out.

Let me break down what the scanner showed me. Edesa Biotech opened at $1.57 and rocketed to a high of $2.58 - that's a 64% intraday move. The stock is currently sitting at $2.20, up 40.13% on the day with volume of 43.2 million shares. For context, this company has a float of just 8.3 million shares, so we're seeing massive volume relative to the available supply. The catalyst? This is an FDA play in the pharmaceutical space, specifically focused on inflammatory and immune-related diseases.

Now here's where it gets interesting from a technical perspective. Using the day's range from the low of $1.51 to the high of $2.58, I'm seeing clean Fibonacci levels that are acting as perfect support and resistance zones. The current price of $2.20 is sitting right at the 61.8% Fibonacci retracement level at $2.17 - this is often called the 'golden ratio' and it's holding as support so far.

Here's my Fibonacci trade plan breakdown: The 38.2% retracement level sits at $1.92, and that's my line in the sand. Below that level, I'm out - no questions asked. That gives us a risk of $0.28 per share from the current price. For targets, I'm looking at a retest of today's high at $2.58 as the first target. But the real opportunity lies in the Fibonacci extensions. The 127.2% extension projects to $2.87, and the 161.8% extension reaches $3.24. That's a potential risk-reward ratio of 1:2.4 to the second target - exactly the kind of setup that gets my attention.

What makes this setup even more compelling is the volume confirmation. When you see 43.2 million shares traded on a stock with only 8.3 million in the float, that tells you institutions are paying attention. Volume confirms everything in my book, and this volume surge validates the breakout move we're seeing.

This is a perfect example of why I always say 'let the scanner do the work.' The combination of catalyst, volume, and technical setup all aligned this morning. The Fibonacci levels are giving us clear risk parameters and profit targets. Whether you're new to trading or experienced, setups like this demonstrate how technical analysis can provide structure to what might otherwise feel like chaos.

The key lesson here? Trade what you see, not what you think. The setup doesn't lie, and when the Fibonacci levels align with fundamental catalysts and volume confirmation, that's when opportunities present themselves. Set up your scanner and find your own.

๐Ÿ’ก Key Takeaway
EDSA shows how FDA catalysts combined with Fibonacci analysis create structured trade opportunities - the 38.2% level at $1.92 provides clear risk management while extensions target $2.87 and beyond.
๐Ÿ“ฌ Free Newsletters You'll Love
โœ“

PennyStocking Daily

The Penny Stock That Just Did 300% โ€” and Why Most Traders Missed It

โœ“

Breakout Profits Weekly

How a Former Student Turned $4K Into $1M+ Using One Chart Pattern

โœ“

Midnight Madness Watchlist

The "Midnight Scan" That Finds Tomorrow's Runners Tonight

โœ“

GAMMA Code Alerts

Why Smart Money Is Loading Up on This One Options Setup Right Now

โœ… You're subscribed! Check your inbox.
4:00:00 remaining

The Morning Income Algorithm Now Scans Twice Daily

Win rate across 1,200+ scans in 2025
Daily opportunities with the new 4 PM after-hours scan
Extra cost โ€” the upgrade is included for current members
Claim Your Seat Before Midnight